Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (89)

1

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma

enthalten in: British journal of haematology | 2024

von Calabretta, E. | di Trani, M. | Corrado, F. | +10

2

Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas

enthalten in: British journal of haematology | 2024

von Dodero, A. | Bramanti, S. | Di Trani, M. | +14

3

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

enthalten in: Blood advances | 2024

von Hamadani, M. | Spira, A. | Zhou, X. | +16

4

PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Alderuccio, J. | Reis, I. | Hamadani, M. | +18

5

Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial) : rationale and study design

enthalten in: Journal of cardiovascular medicine (Hagerstown, Md.) | 2023

von Cannata, F. | Stefanini, G. | Carlo-Stella, C. | +18

6

Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma

enthalten in: Blood | 2023

von Santoro, A. | Moskowitz, A. | Ferrari, S. | +6

CommentIn: Blood. 2023 Jun 1;141(22):2673-2674. - PMID 37261857

7

Tumor microenvironment contribution to checkpoint blockade therapy : lessons learned from Hodgkin lymphoma

enthalten in: Blood | 2023

von Carbone, A. | Gloghini, A. | Carlo-Stella, C.

8

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma : A phase 1/2 study

enthalten in: Cancer medicine | 2023

von Lesokhin, A. | LeBlanc, R. | Dimopoulos, M. | +18

9

Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Lambri, N. | Antonetti, S. | Dei, D. | +16

10

BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas

enthalten in: Nature communications | 2023

von Moreno, V. | Vieito, M. | Sepulveda, J. | +18

1
2
3
4
5
6
7
8
9
Nächster »
[9]